BioTie Therapies Chooses Tripos as Partner in Drug Discovery

Tripos, a leading provider of drug discovery chemistry and informatics products and services, and BioTie Therapies, a Finnish biotech company, have announced a partnership to enhance BioTie's drug discovery efforts, which include innovative medicines for the treatment of dependence disorders, inflammatory diseases and thrombosis. Under the agreement, Tripos will identify and optimize backup series for one of BioTie's key drug discovery programs.
Yahoo News